Page last updated: 2024-09-03

marimastat and Melanoma

marimastat has been researched along with Melanoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altevogt, P; Arnold, A; Cerwenka, A; Fiegler, N; Moldenhauer, G; Paschen, A; Rose-John, S; Schlecker, E; Sucker, A; Textor, S; von Strandmann, EP1
Belanger, K; Bodurth, A; Eisenhauer, E; Lohmann, R; Quirt, I; Rusthoven, J; Stewar, W; Wainman, N; Young, V1
McCann, PP; Rasmussen, HS1

Reviews

1 review(s) available for marimastat and Melanoma

ArticleYear
Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.
    Pharmacology & therapeutics, 1997, Volume: 75, Issue:1

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Colorectal Neoplasms; Enzyme Inhibitors; Female; Hemangioma; Humans; Hydroxamic Acids; Melanoma; Metalloendopeptidases; Mice; Ovarian Neoplasms; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Skin Neoplasms; Thiophenes

1997

Trials

1 trial(s) available for marimastat and Melanoma

ArticleYear
Phase II study of marimastat (BB-2516) in malignant melanoma: a clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group.
    Investigational new drugs, 2002, Volume: 20, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Protocols; Biopsy; Canada; Female; Humans; Hydroxamic Acids; Male; Melanoma; Metalloendopeptidases; Middle Aged

2002

Other Studies

2 other study(ies) available for marimastat and Melanoma

ArticleYear
Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.
    Cancer research, 2014, Jul-01, Volume: 74, Issue:13

    Topics: ADAM Proteins; ADAM10 Protein; ADAM17 Protein; Amyloid Precursor Protein Secretases; B7 Antigens; Cell Line, Tumor; Dipeptides; HCT116 Cells; HeLa Cells; Humans; Hydroxamic Acids; Killer Cells, Natural; Lymphocyte Activation; MCF-7 Cells; Melanoma; Membrane Proteins; Natural Cytotoxicity Triggering Receptor 3; Phenylalanine; Protease Inhibitors; RNA Interference; RNA, Messenger; RNA, Small Interfering; Thiophenes; Tumor Escape; Up-Regulation

2014
Marimastat. BB 2516, TA 2516.
    Drugs in R&D, 1999, Volume: 1, Issue:2

    Topics: Adult; Antineoplastic Agents; Colorectal Neoplasms; Drugs, Investigational; Female; Humans; Hydroxamic Acids; Male; Melanoma; Metalloendopeptidases; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Protease Inhibitors; Stomach Neoplasms

1999